Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-08-11 17:43:57 ET · period of report 2026-08-10 · accession 0001662521-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-11 17:43 | 2026-08-10 | HALO | Connaughton Bernadette | Dir | S - Sale | $102.80 | -1,626 | 40.4K | -4% | -$167.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-10 | S | D | 1,626 | $102.80 | 40,418 | D | — | — | (F1) The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1. |